Gene expression profiling identifies STAT3 as a novel pathway for immunomodulation by cholera toxin adjuvant

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Cholera toxin (CT) exhibits both pro-inflammatory and anti-inflammatory activities.
• CT is a potent immune adjuvant, necessitating investigation into its underlying molecular mechanisms.
• Previous studies have yielded conflicting results regarding CT's immunomodulatory effects.

Purpose of the Study:

• To identify genes involved in the pro- and anti-inflammatory functions of CT.
• To elucidate the molecular mechanism by which CT influences B cell responses.
• To reconcile the disparate findings on CT's adjuvant properties.

Main Methods:

• Global gene expression analysis in mouse B cells treated with CT.
• Investigation of signal transducer and activator of transcription (STAT)3 expression and activation in B cells (in vitro and in vivo).
• Assessment of B cell responses to interleukin (IL)-6 and IL-10 following CT pre-exposure, including proliferation and cytokine production.

Main Results:

• CT regulated fewer than 100 annotated genes in mouse B cells, including STAT3.
• CT increased STAT3 expression and activation in a cAMP-dependent manner, independent of CTB.
• CT-exposed B cells showed enhanced STAT3 activation by IL-6 and IL-10, leading to increased IgG1 and IgA production and altered IL-10 effects on LPS-stimulated B cells.

Conclusions:

• CT modulates STAT3 signaling in B cells, providing a molecular basis for its dual immunomodulatory effects.
• This study reconciles previous observations of CT's pro- and anti-inflammatory roles.
• CT's adjuvant activity is linked to its influence on STAT3 pathways and subsequent B cell responses.